Reagent | Specificity/origin | Concentration | Relative protease stability (%) a | |
---|---|---|---|---|
Inhibitor/reducing agents | Control |  | – | 100 ± 2.5 |
PMSF or DFP | Serine protease specific inhibitors | 5 mM | 0 ± 0.0 | |
Benzamidine | Competitive inhibitor of serine proteases | 10 mM | 103 ± 2.6 | |
Aprotinin | 5 mM | 101 ± 2.5 | ||
SBTI | Soybean trypsin inhibitor | 3 mg/mL | 101 ± 2.5 | |
TPCK | Chymotrypsin specific inhibitor | 1 mM | 94 ± 2.2 | |
TLCK | Trypsin-like specific inhibitor | 1 mM | 102 ± 2.5 | |
DTNB | Cysteine or thiol-containing protease inhibitors | 5 mM | 41 ± 0.8 | |
NEM | 5 mM | 74 ± 1.8 | ||
MIA | 10 mM | 97 ± 2.4 | ||
EPNP | 2 mM | 87 ± 2.1 | ||
Iodoacetamide | 50 μg/mL | 65 ± 1.4 | ||
β-ME | Thiol reducing agent for cleaving protein disulfide bonds (cystin) | 1 mM | 66 ± 1.6 | |
ld-DTT | 50 μM | 61 ± 1.5 | ||
EDTA | Specific metallo-protease inhibitors | 1 mM | 91 ± 2.2 | |
EGTA | 2 mM | 80 ± 2.1 | ||
1,10-Phenanthroline monohydrate | 10 mM | 102 ± 2.5 | ||
Leupeptine | Acid protease specific inhibitors | 10 μg/mL | 101 ± 2.5 | |
Pepstatine A | 10 mM | 104 ± 2.7 | ||
Metallic ions | Control |  | – | 100 ± 2.5 |
Ca2+ | CaCl2 | 2 mM | 270 ± 6.0 | |
Mg2+ | MgCl2 | 2 mM | 180 ± 3.8 | |
Fe2+ | FeCl2 | 2 mM | 145 ± 3.4 | |
Cu2+ | CuCl2 | 2 mM | 99 ± 2.5 | |
Mn2+ | MnCl2 | 2 mM | 109 ± 2.6 | |
Co2+ | CoCl2 | 2 mM | 61 ± 1.2 | |
Ba2+ | BaCl2 | 2 mM | 75 ± 1.8 | |
Zn2+ | ZnCl2 | 2 mM | 40 ± 0.8 | |
Hg2+ or Cd2+ or Ni2+ | HgCl2, CdCl2, or NiCl2 | 2 mM | 0 ± 0.0 |